CIK 0001831828 · Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812744449
- Phone
- 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-23 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +18,500 | $2.90 | $54K | 253,744 |
| 2026-06-23 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −18,412 | $37.93 | $698K | 235,332 |
| 2026-06-23 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −88 | $38.43 | $3K | 235,244 |
| 2026-06-23 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,500 | 572,051 | ||
| 2026-06-23 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −18,412 | $37.93 | $698K | 198,332 |
| 2026-06-23 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −88 | $38.43 | $3K | 198,244 |
| 2026-05-21 | Hall Kimball Director | Grant or award · Stock Option (right to buy) | +17,084 | 17,084 | ||
| 2026-05-21 | Oliger Christy J. Director | Grant or award · Stock Option (right to buy) | +17,084 | 17,084 | ||
| 2026-05-21 | Cheng Andrew Director | Grant or award · Stock Option (right to buy) | +17,084 | 17,084 | ||
| 2026-05-21 | Morrison Scott W Director | Grant or award · Stock Option (right to buy) | +17,084 | 17,084 | ||
| 2026-05-21 | Meyers James R Director | Grant or award · Stock Option (right to buy) | +17,084 | 17,084 | ||
| 2026-05-21 | ENRIGHT PATRICK G Director | Grant or award · Stock Option (right to buy) | +17,084 | 17,084 | ||
| 2026-05-21 | MORRISSEY MICHAEL Director | Grant or award · Stock Option (right to buy) | +17,084 | 17,084 | ||
| 2026-05-21 | SEIDENBERG BETH C Director | Grant or award · Stock Option (right to buy) | +17,084 | 17,084 | ||
| 2026-05-12 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +18,500 | $2.90 | $54K | 253,744 |
| 2026-05-12 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −14,219 | $36.64 | $521K | 239,525 |
| 2026-05-12 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −4,281 | $37.09 | $159K | 235,244 |
| 2026-05-12 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,500 | 590,551 | ||
| 2026-05-12 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −14,219 | $36.64 | $521K | 221,025 |
| 2026-05-12 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −4,281 | $37.09 | $159K | 216,744 |
Page 2 of 17 · 321 trades